The use of high frequency oscillator ventilation (HFOV) in paediatric acute respiratory distress syndrome (ARDS) with open lung technique

ISRCTN ISRCTN19924570
DOI https://doi.org/10.1186/ISRCTN19924570
Secondary identifying numbers N/A
Submission date
21/08/2009
Registration date
07/09/2009
Last edited
08/09/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Rujipat Samransamruajkit
Scientific

King Chulalongkorn Memorial Hospital
Pediatric Pulmonary & Critical Care
Praram 4 road, Pathum-one
Bangkok
10330
Thailand

Phone +66 (0)2 256 4908
Email rujsam@hotmail.com

Study information

Study designProspective interventional open label trial
Primary study designInterventional
Secondary study designNon randomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleThe use of high frequency oscillator ventilation (HFOV) in paediatric acute respiratory distress syndrome (ARDS) with open lung technique: a prospective, interventional open label trial
Study objectivesTo determine the efficacy and feasibility of high frequency oscillator ventilation (HFOV) in children with acute respiratory distress syndrome (ARDS) by using HFOV combined with an open lung technique.
Ethics approval(s)Approved by the Institutional Review Board of the Faculty of Medicine, Chulalongkorn University, Thailand, on the 5th April 2007 (ref: 236/2007; REC N0 002/50)
Health condition(s) or problem(s) studiedPaediatic acute respiratory distress syndrome (ARDS)
InterventionRecruitment protocol:
Body weight less than 35 kg (use of 3100 A):
1. Select patient (central line and/or arterial lines were placed prior to the manouevre)
2. Stable VS (optimised preload/use of inotrope) were required in all patients enrolling in the study. Start initial setting of HFOV, FiO2 1, MAP 30 cmH2O (turn piston off), 20 secs then gradually weaned MAP down to 5 - 8 cmH2O above previous conventional ventilator MAP (keep oxygen sat greater than 92%).

Body weight greater than 35 kg (use of 3100B):
1. Select patient (central line and/or arterial line were placed prior to the recruitment manouevre)
2. Stable VS (optimised preload/use of inotrope/vasopressor) were required. Start initial setting of HFOV, FiO2 1, MAP 35 cmH2O (turn piston off), 30 seconds then gradually wean MAP down to 5 - 8 cmH2O above conventional ventilator. (Consider stopping procedure if unstable VS, BP drop and cannot correct by volume resuscitation or inotrope titration). The RMs can be repeated but not more than twice/day during the first 3 days if FiO2 could not weaned down more than 0.6, other ventilator adjustment was followed by the HFOV operation protocol.
3. If patients failed to keep oxygen saturation above 95% on the first trial of RM, repeat RM with raised mPaw to +3 cmH2O above the previous mPaw followed by weaning down the mPaw gradually every 3 - 5 minutes until it reached 5 - 8 cmH2O above the previous CV mPaw or the oxygen saturation start to drop below 95%. The RM will be done only in the first three days.

Body weight less than 35 kg (use of 3100 A):
1. Select patient (central line and/or arterial line were placed prior to the recruitment manouevre)
2. Stable VS (optimised preload/use of inotrope) were required. (Consider stopping procedure if unstable VS, BP drop and could not correct by volume resuscitation or inotrope titration). The RMs were repeated but not more than twice/day during the first 3 days if FiO2 could not wean down more than 0.6, other ventilator adjustment were followed by HFOV our operation protocol. Also blood samples were collected at baseline, 1 hour after initial RM procedure and 24 hours thereafter.
3. Adjust other ventilator settings and wean were followed HFOV protocol or per PICU attendings.
4. The patients were switched back to CV mode if mPaw stay in the range of 22 - 24 cmH2O, on FiO2 equalling 0.4, or on HFOV greater than 24 hours and have overall clinical stable for more than 24 hours.
5. The patients were placed back on HFOV if intolerance to CV, e.g. oxygen saturation less than 88% was more than 15 minutes (FiO2 greater than 0.6) or Ph less than 7.3 and by greater than 0.1 from last HFOV value.

Use of high frequency oscillator ventilation with open lung technique for the first three days.
Intervention typeOther
Primary outcome measureOxygenation response, measured at 28 days in PICU
Secondary outcome measuresMortality, measured at 28 days in PICU
Overall study start date01/01/2007
Completion date31/12/2008

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit1 Month
Upper age limit15 Years
SexBoth
Target number of participants20 - 30 patients
Key inclusion criteria1. Paediatric patients aged greater than 1 month to less than 15 years old (from January 2007 - November 2008), either sex
2. Diagnosis of ARDS within 72 hours of Paediatric Intensive Care Unit (PICU) admission
3. No exclusion criteria
Key exclusion criteria1. Pulmonary capillary wedge pressure greater than or equal to 18 mmHg
2. Evidence of left atrial hypertension
3. Severe irreversible neurological injury or intractable shock
4. The underlying disease was deemed irreversible or ARDS greater than 48 hours
5. Pre-existing air leak syndrome (e.g., pneumothorax or pneumomediastinum)
6. Pre-existing cystic lung disease
Date of first enrolment01/01/2007
Date of final enrolment31/12/2008

Locations

Countries of recruitment

  • Thailand

Study participating centre

King Chulalongkorn Memorial Hospital
Bangkok
10330
Thailand

Sponsor information

Rachada Pisek Somphotch (Thailand)
University/education

King Chulalongkorn Memorial Hospital
Praram 4 Road
Pathumone
Bangkok
10330
Thailand

Phone +66 (0)2 256 4455
Email Jang_rung@hotmail.com

Funders

Funder type

Industry

Rachada Pisek Somphotch (Thailand) - Local University Fund

No information available

Viasys Healthcare (Thailand)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan